BIOGEN INC. Increase (Decrease) in Other Operating Assets and Liabilities, Net
BIOGEN INC. (BIIB) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of $89.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2026-04-29
- BIOGEN INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-03-31 was $89.00M, a 66.36% increase year-over-year.
- BIOGEN INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-12-31 was -$119.30M.
- BIOGEN INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-09-30 was $104.40M.
- BIOGEN INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-06-30 was $22.00M, a 53.09% decline year-over-year.
- BIOGEN INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2025 was $60.60M, a 115.66% increase from fiscal 2024.
- BIOGEN INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2024 was $28.10M, a 510.87% increase from fiscal 2023.
- BIOGEN INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2023 was $4.60M, a 75.79% decline from fiscal 2022.
- BIOGEN INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2022 was $19.00M.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $89.00M 10-Q · filed 2026-04-29 | -$30.30M derived: sum of 2 quarters · filed 2026-04-29 | $74.10M derived: sum of 3 quarters · filed 2026-04-29 | $96.10M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | -$119.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$14.90M derived: sum of 2 quarters · filed 2026-02-06 | $7.10M derived: sum of 3 quarters · filed 2026-02-06 | $60.60M 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | $104.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $126.40M derived: sum of 2 quarters · filed 2025-10-30 | $179.90M 10-Q · filed 2025-10-30 | $142.30M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | $22.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $75.50M 10-Q · filed 2025-07-31 | $37.90M derived: sum of 3 quarters · filed 2026-04-29 | $600.00K derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | $53.50M 10-Q · filed 2026-04-29 | $15.90M derived: sum of 2 quarters · filed 2026-04-29 | -$21.40M derived: sum of 3 quarters · filed 2026-04-29 | $25.50M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | -$37.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$74.90M derived: sum of 2 quarters · filed 2026-02-06 | -$28.00M derived: sum of 3 quarters · filed 2026-02-06 | $28.10M 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | -$37.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $9.60M derived: sum of 2 quarters · filed 2025-10-30 | $65.70M 10-Q · filed 2025-10-30 | -$1.10M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | $46.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $103.00M 10-Q · filed 2025-07-31 | $36.20M derived: sum of 3 quarters · filed 2026-02-06 | $52.10M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | $56.10M 10-Q · filed 2025-05-01 | -$10.70M derived: sum of 2 quarters · filed 2026-02-06 | $5.20M derived: sum of 3 quarters · filed 2026-02-06 | -$36.10M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | -$66.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$50.90M derived: sum of 2 quarters · filed 2026-02-06 | -$92.20M derived: sum of 3 quarters · filed 2026-02-06 | $4.60M 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | $15.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$25.40M derived: sum of 2 quarters · filed 2024-10-30 | $71.40M 10-Q · filed 2024-10-30 | $106.30M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | -$41.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $55.50M 10-Q · filed 2024-08-01 | $90.40M derived: sum of 3 quarters · filed 2025-02-12 | -$59.50M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | $96.80M 10-Q · filed 2024-04-24 | $131.70M derived: sum of 2 quarters · filed 2025-02-12 | -$18.20M derived: sum of 3 quarters · filed 2025-02-12 | -$97.80M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | $34.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$115.00M derived: sum of 2 quarters · filed 2025-02-12 | -$194.60M derived: sum of 3 quarters · filed 2025-02-12 | $19.00M 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | -$149.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$229.50M derived: sum of 2 quarters · filed 2023-11-08 | -$15.90M 10-Q · filed 2023-11-08 | -$104.70M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | -$79.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $134.00M 10-Q · filed 2023-07-25 | $45.20M derived: sum of 3 quarters · filed 2024-02-14 | $35.50M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | $213.60M 10-Q · filed 2023-04-25 | $124.80M derived: sum of 2 quarters · filed 2024-02-14 | $115.10M derived: sum of 3 quarters · filed 2024-02-14 | $131.50M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | -$88.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$98.50M derived: sum of 2 quarters · filed 2024-02-14 | -$82.10M derived: sum of 3 quarters · filed 2024-02-14 | -$1.20M 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | -$9.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | $6.70M derived: sum of 2 quarters · filed 2022-10-25 | $87.60M 10-Q · filed 2022-10-25 | -$186.10M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | $16.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | $97.30M 10-Q · filed 2022-07-20 | -$176.40M derived: sum of 3 quarters · filed 2023-02-15 | -$69.50M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | $80.90M 10-Q · filed 2022-05-03 | -$192.80M derived: sum of 2 quarters · filed 2023-02-15 | -$85.90M derived: sum of 3 quarters · filed 2023-02-15 | -$77.30M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | -$273.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$166.80M derived: sum of 2 quarters · filed 2023-02-15 | -$158.20M derived: sum of 3 quarters · filed 2023-02-15 | -$176.70M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | $106.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | $115.50M derived: sum of 2 quarters · filed 2021-10-20 | $97.00M 10-Q · filed 2021-10-20 | $154.70M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | $8.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-22 | -$9.90M 10-Q · filed 2021-07-22 | $47.80M derived: sum of 3 quarters · filed 2022-02-03 | $3.70M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | -$18.50M 10-Q · filed 2021-04-22 | $39.20M derived: sum of 2 quarters · filed 2022-02-03 | -$4.90M derived: sum of 3 quarters · filed 2022-02-03 | -$126.30M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | $57.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $13.60M derived: sum of 2 quarters · filed 2022-02-03 | -$107.80M derived: sum of 3 quarters · filed 2022-02-03 | $63.30M 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | -$44.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-21 | -$165.50M derived: sum of 2 quarters · filed 2020-10-21 | $5.60M 10-Q · filed 2020-10-21 | $61.00M 10-Q · filed 2019-10-22 | -$81.10M derived: sum of 4 quarters · filed 2021-02-03 | |||
| 2019-06-30 | -$121.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-22 | $49.70M 10-Q · filed 2020-07-22 | $80.30M 10-Q · filed 2019-07-24 | -$37.00M derived: sum of 3 quarters · filed 2021-02-03 | $52.70M derived: sum of 4 quarters · filed 2021-02-03 | |||
| 2019-03-31 | $171.10M 10-Q · filed 2020-04-23 | $84.40M derived: sum of 2 quarters · filed 2021-02-03 | $174.10M derived: sum of 3 quarters · filed 2021-02-03 | $145.40M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | -$86.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $3.00M derived: sum of 2 quarters · filed 2021-02-03 | -$25.70M derived: sum of 3 quarters · filed 2021-02-03 | -$5.70M 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | $89.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | $61.00M derived: sum of 2 quarters · filed 2019-10-22 | $81.00M 10-Q · filed 2019-10-22 | $62.80M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | -$28.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$8.70M 10-Q · filed 2019-07-24 | -$26.90M derived: sum of 3 quarters · filed 2020-02-06 | $36.00M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-03-31 | $20.00M 10-Q · filed 2019-04-24 | $1.80M derived: sum of 2 quarters · filed 2020-02-06 | $64.70M derived: sum of 3 quarters · filed 2020-02-06 | $217.70M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | -$18.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $44.70M derived: sum of 2 quarters · filed 2020-02-06 | $197.70M derived: sum of 3 quarters · filed 2020-02-06 | $232.00M 10-K · filed 2020-02-06 | ||||
| 2017-09-30 | $62.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | $215.90M derived: sum of 2 quarters · filed 2018-10-23 | $250.20M 10-Q · filed 2018-10-23 | $298.30M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-06-30 | $153.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-24 | $187.30M 10-Q · filed 2018-07-24 | $235.40M derived: sum of 3 quarters · filed 2019-02-06 | $148.30M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-03-31 | $34.30M 10-Q · filed 2018-04-24 | $82.40M derived: sum of 2 quarters · filed 2019-02-06 | -$4.70M derived: sum of 3 quarters · filed 2019-02-06 | -$16.50M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2016-12-31 | $48.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | -$39.00M derived: sum of 2 quarters · filed 2019-02-06 | -$50.80M derived: sum of 3 quarters · filed 2019-02-06 | -$13.90M 10-K · filed 2019-02-06 | ||||
| 2016-09-30 | -$87.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | -$98.90M derived: sum of 2 quarters · filed 2017-10-24 | -$62.00M 10-Q · filed 2017-10-24 | -$62.10M 10-Q · filed 2016-10-26 | -$151.40M derived: sum of 4 quarters · filed 2018-02-01 | |||
| 2016-06-30 | -$11.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | $25.10M 10-Q · filed 2017-07-25 | -$50.10M 10-Q · filed 2016-07-21 | -$64.30M derived: sum of 3 quarters · filed 2018-02-01 | -$10.20M derived: sum of 4 quarters · filed 2018-02-01 | |||
| 2016-03-31 | $36.90M 10-Q · filed 2017-04-25 | -$14.80M 10-Q · filed 2016-04-21 | -$52.50M derived: sum of 2 quarters · filed 2018-02-01 | $1.60M derived: sum of 3 quarters · filed 2018-02-01 | -$1.70M derived: sum of 4 quarters · filed 2018-02-01 | |||
| 2015-12-31 | -$89.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | -$35.30M derived: sum of 2 quarters · filed 2018-02-01 | -$38.60M derived: sum of 3 quarters · filed 2018-02-01 | $31.10M 10-K · filed 2018-02-01 | ||||
| 2015-09-30 | $54.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | $50.80M derived: sum of 2 quarters · filed 2016-10-26 | $120.50M 10-Q · filed 2016-10-26 | $121.66M 10-Q · filed 2015-10-21 | $174.10M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-06-30 | -$3.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-21 | $66.40M 10-Q · filed 2016-07-21 | $66.37M 10-Q · filed 2015-07-24 | $120.00M derived: sum of 3 quarters · filed 2017-02-02 | $22.06M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-03-31 | $69.70M 10-Q · filed 2016-04-21 | $69.71M 10-Q · filed 2015-04-24 | $123.30M derived: sum of 2 quarters · filed 2017-02-02 | $25.36M derived: sum of 3 quarters · filed 2017-02-02 | $43.70M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | $53.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | -$44.34M derived: sum of 2 quarters · filed 2017-02-02 | -$26.00M derived: sum of 3 quarters · filed 2017-02-02 | $30.70M 10-K · filed 2017-02-02 | $30.70M 10-K · filed 2015-02-04 | |||
| 2014-09-30 | -$97.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21 | -$79.60M derived: sum of 2 quarters · filed 2015-10-21 | -$22.90M 10-Q · filed 2015-10-21 | $48.87M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-06-30 | $18.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-24 | $75.04M 10-Q · filed 2015-07-24 | $43.93M 10-Q · filed 2014-07-23 | $146.82M derived: sum of 3 quarters · filed 2016-02-03 | $144.18M derived: sum of 4 quarters · filed 2016-02-03 | |||
| 2014-03-31 | $56.70M 10-Q · filed 2015-04-24 | $75.34M 10-Q · filed 2014-04-23 | $128.47M derived: sum of 2 quarters · filed 2016-02-03 | $125.83M derived: sum of 3 quarters · filed 2016-02-03 | $76.21M derived: sum of 4 quarters · filed 2016-02-03 | |||
| 2013-12-31 | $71.77M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $69.14M derived: sum of 2 quarters · filed 2016-02-03 | $19.51M derived: sum of 3 quarters · filed 2016-02-03 | -$15.70M 10-K · filed 2016-02-03 | -$15.73M 10-K · filed 2014-02-06 | |||
| 2013-09-30 | -$2.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-22 | -$52.26M derived: sum of 2 quarters · filed 2014-10-22 | -$87.47M 10-Q · filed 2014-10-22 | -$198.27M 10-Q · filed 2013-10-28 | $23.88M derived: sum of 4 quarters · filed 2015-02-04 | |||
| 2013-06-30 | -$49.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-23 | -$84.84M 10-Q · filed 2014-07-23 | -$68.87M 10-Q · filed 2013-07-25 | $26.52M derived: sum of 3 quarters · filed 2015-02-04 | -$19.48M derived: sum of 4 quarters · filed 2015-02-04 | |||
| 2013-03-31 | -$35.21M 10-Q · filed 2014-04-23 | $76.14M derived: sum of 2 quarters · filed 2015-02-04 | $30.14M derived: sum of 3 quarters · filed 2015-02-04 | $3.45M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | $111.36M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $65.36M derived: sum of 2 quarters · filed 2015-02-04 | $38.66M derived: sum of 3 quarters · filed 2015-02-04 | $39.67M 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | -$46.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | -$72.69M derived: sum of 2 quarters · filed 2013-10-28 | -$71.69M 10-Q · filed 2013-10-28 | $32.39M 10-Q · filed 2012-10-25 | -$125.33M derived: sum of 4 quarters · filed 2014-02-06 | |||
| 2012-06-30 | -$26.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | -$25.68M 10-Q · filed 2013-07-25 | $70.65M 10-Q · filed 2012-07-24 | -$79.33M derived: sum of 3 quarters · filed 2014-02-06 | -$88.68M derived: sum of 4 quarters · filed 2014-02-06 | |||
| 2012-03-31 | $1.01M 10-Q · filed 2013-04-25 | $20.04M 10-Q · filed 2012-05-01 | -$52.64M derived: sum of 2 quarters · filed 2014-02-06 | -$61.98M derived: sum of 3 quarters · filed 2014-02-06 | $13.91M derived: sum of 4 quarters · filed 2014-02-06 | |||
| 2011-12-31 | -$53.65M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | -$62.99M derived: sum of 2 quarters · filed 2014-02-06 | $12.90M derived: sum of 3 quarters · filed 2014-02-06 | $6.26M 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | -$9.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-25 | $66.55M derived: sum of 2 quarters · filed 2012-10-25 | $59.91M 10-Q · filed 2012-10-25 | |||||
| 2011-06-30 | $75.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-24 | $69.26M 10-Q · filed 2012-07-24 | ||||||
| 2011-03-31 | -$6.64M 10-Q · filed 2012-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |